about
Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasisThe two variants of oxysterol binding protein-related protein-1 display different tissue expression patterns, have different intracellular localization, and are functionally distinctGenes of cholesterol metabolism in human atheroma: overexpression of perilipin and genes promoting cholesterol storage and repression of ABCA1 expressionActivation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophagesPeroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolismDownregulation of the tumour suppressor p16INK4A contributes to the polarisation of human macrophages toward an adipose tissue macrophage (ATM)-like phenotypeHDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotypeRole of proinflammatory CD68(+) mannose receptor(-) macrophages in peroxiredoxin-1 expression and in abdominal aortic aneurysms in humans.The role of PPARs in atherosclerosis.Rupture of the atherosclerotic plaque: does a good animal model exist?Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages.Therapeutical effects of PPAR agonists assessed by biomarker modulation.Macrophage polarization in metabolic disorders: functions and regulationp16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages.Measuring biomarkers to assess the therapeutic effects of PPAR agonists?Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men.Natalizumab Treatment Modulates Peroxisome Proliferator-Activated Receptors Expression in Women with Multiple Sclerosis.Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production.Macrophage phenotypes and their modulation in atherosclerosis.Macrophage phenotypes in atherosclerosis.Macrophage subsets in atherosclerosis.Liver X receptor activation stimulates iron export in human alternative macrophages.miR-206 controls LXRα expression and promotes LXR-mediated cholesterol efflux in macrophagesPeroxisome Proliferator-Activated Receptor γ Induces the Expression of Tissue Factor Pathway Inhibitor-1 (TFPI-1) in Human Macrophages.Adipose tissue macrophages (ATM) of obese patients are releasing increased levels of prolactin during an inflammatory challenge: a role for prolactin in diabesity?A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity.The neuron-derived orphan receptor 1 (NOR1) is induced upon human alternative macrophage polarization and stimulates the expression of markers of the M2 phenotype.Structural and functional changes in HDL with low grade and chronic inflammation.PPARs/RXRs in Cardiovascular Physiology and Disease.Peroxisome proliferator-activated receptor-γ activation induces 11β-hydroxysteroid dehydrogenase type 1 activity in human alternative macrophages.Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways.Peroxisome proliferator-activated receptor alpha reduces cholesterol esterification in macrophages.Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR.Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis.Peroxisome proliferator-activated receptor alpha induces NADPH oxidase activity in macrophages, leading to the generation of LDL with PPAR-alpha activation properties.Peroxisome proliferator-activated receptor (PPAR) agonists decrease lipoprotein lipase secretion and glycated LDL uptake by human macrophages.Free leptin, carotid plaque phenotype and relevance to related symptomatology: insights from the OPAL-Lille carotid endarterectomy study.Liver X receptor activation induces the uptake of cholesteryl esters from high density lipoproteins in primary human macrophages.Macrophage function and polarization in cardiovascular disease: a role of estrogen signaling?Peroxisome proliferator-activated receptor alpha controls cellular cholesterol trafficking in macrophages.
P50
Q24541529-8C17F129-E375-4BD9-8BC9-6F9320BADBDBQ24554292-E796D866-2756-49F3-834F-FC4332D4776EQ28257152-2792B7FD-534F-4886-B221-3781FEA3E35EQ28283333-6B485E1F-55A0-47A0-8C22-79E42AB1F4B6Q28583502-72DC3005-B545-4300-A7D8-A17C38C4995EQ33610073-E9FE2FDE-26F4-4686-9C36-8CB16E762D40Q34427695-885EEE3A-8C3C-4974-B89D-4A2215B63B76Q34513260-978AA657-A275-4F88-A9B9-38FAF8D79C13Q34838209-B1E5438B-A3A8-4E9D-8621-C9AEAD8749CFQ35077352-844A3EE7-D7BF-4579-97CB-26714136D4C4Q35244183-9C4D4E6F-2360-4EFC-B347-9EA09735DDCCQ36317991-88F07A6F-3FA8-45EF-8040-9775EC38EE6AQ36591717-BFD92708-6082-40B9-B354-CC81D179B81EQ36916423-BF580646-B198-467D-A8C7-FD51B30FE2CDQ37012012-F793D9F0-4733-470C-B7C9-2822790B952DQ37103503-B9836C22-42A1-4F55-B719-47D451ED74ADQ37547689-99CE89CA-0AE5-4107-A133-EC88F58D019AQ37699483-66F15E51-A0A5-44B1-A810-62784EC2F594Q38226669-5C174CBE-1F2B-49CE-A942-A90F21592225Q38260570-76BEEC11-C5B9-412A-AF2C-89D4D205B0BEQ38264834-0A521643-EF8F-4FE3-84BD-9A5A4B164B35Q38792119-0E3AB09B-44CE-4011-BB4B-A326C8AE3E4CQ38916069-4AB89DDB-54EC-4D05-83B7-B5FF2D711FC5Q39003245-96FCB3D9-9102-439A-AAA3-4F2F0631FF6DQ39041197-2BAC92F7-44B8-4FD4-B4D5-67310F950191Q40930373-61DC2B81-0EA4-45A0-85EC-BC92445A25E1Q40975637-0FF1867B-7BD6-46D1-A529-8B726E8E176CQ41278315-5B6AF4A0-597E-4DB5-AE40-18E0533CBB23Q42152639-B97C7FE5-7BF6-4C68-9EF3-3AF8B7D7D45CQ42321362-4161A3F0-23D6-4BC7-A6D7-61CF9FE25E49Q42557215-7DC80A79-C3C3-4A6C-93BC-FDAA71D99F4BQ44306746-B920F504-CAD3-4A05-B077-3AE3C24DC779Q44722370-70FD14FC-AE70-4AE0-9A94-1C9DD0ADDC8BQ45050542-6D6EE743-AA93-49A2-A1AC-3BC84498371EQ45148001-08F5CA5E-1E58-422F-8BC7-57AE5BEFC0D1Q45711444-D5632882-6351-48BA-90EF-7CD95783BEC8Q45787291-57FBCBD5-AC5F-430B-8B53-2900A5CFDDE8Q46359185-41EBBAEE-9D73-4265-9EC4-ED7C94F52884Q46667004-35AF1CF0-A0D7-4560-97BF-A072253BFED7Q46703458-2CB5F650-9A21-4078-A18F-DE10E751AE23
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Giulia Chinetti
@ast
Giulia Chinetti
@en
Giulia Chinetti
@es
Giulia Chinetti
@fr
Giulia Chinetti
@it
Giulia Chinetti
@nl
Giulia Chinetti
@sl
type
label
Giulia Chinetti
@ast
Giulia Chinetti
@en
Giulia Chinetti
@es
Giulia Chinetti
@fr
Giulia Chinetti
@it
Giulia Chinetti
@nl
Giulia Chinetti
@sl
prefLabel
Giulia Chinetti
@ast
Giulia Chinetti
@en
Giulia Chinetti
@es
Giulia Chinetti
@fr
Giulia Chinetti
@it
Giulia Chinetti
@nl
Giulia Chinetti
@sl
P1053
Q-6901-2016
P106
P21
P31
P3829
P496
0000-0001-8048-8138